Strekin was founded in 2014 by Dr. Alexander Bausch, and its focus is on discovering the therapeutic potential in existing molecules to transform the lives of patients with diseases of stress-related inflammatory pathways.
Clinical trials to be announced.
RECENT NEWS ON STREKIN
Sorry, no posts matched your criteria
Locations: Switzerland Year Founded: 2014 CEO: Alexander Bausch (Ph.D.)